DK0635132T3 - Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener - Google Patents

Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Info

Publication number
DK0635132T3
DK0635132T3 DK93907460T DK93907460T DK0635132T3 DK 0635132 T3 DK0635132 T3 DK 0635132T3 DK 93907460 T DK93907460 T DK 93907460T DK 93907460 T DK93907460 T DK 93907460T DK 0635132 T3 DK0635132 T3 DK 0635132T3
Authority
DK
Denmark
Prior art keywords
react
broadly reactive
opsonic antibodies
staphylococcal antigens
reactive opsonic
Prior art date
Application number
DK93907460T
Other languages
English (en)
Other versions
DK0635132T4 (da
Inventor
Gerald W Fischer
Original Assignee
Jackson H M Found Military Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26709752&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0635132(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Jackson H M Found Military Med filed Critical Jackson H M Found Military Med
Application granted granted Critical
Publication of DK0635132T3 publication Critical patent/DK0635132T3/da
Publication of DK0635132T4 publication Critical patent/DK0635132T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1271—Micrococcaceae (F); Staphylococcaceae (F), e.g. Staphylococcus (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK93907460T 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener DK0635132T4 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85402792A 1992-03-19 1992-03-19
US3347693A 1993-03-18 1993-03-18
PCT/US1993/002275 WO1993019373A1 (en) 1992-03-19 1993-03-18 Broadly reactive opsonic antibodies that react with common staphylococcal antigens

Publications (2)

Publication Number Publication Date
DK0635132T3 true DK0635132T3 (da) 2001-02-26
DK0635132T4 DK0635132T4 (da) 2008-08-25

Family

ID=26709752

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93907460T DK0635132T4 (da) 1992-03-19 1993-03-18 Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener

Country Status (12)

Country Link
EP (3) EP0635132B2 (da)
JP (3) JP4124816B2 (da)
AT (1) ATE197506T1 (da)
AU (1) AU3805893A (da)
CA (1) CA2132421C (da)
DE (1) DE69329642T3 (da)
DK (1) DK0635132T4 (da)
ES (1) ES2155450T5 (da)
GR (1) GR3035155T3 (da)
IL (1) IL105119A (da)
PT (1) PT635132E (da)
WO (1) WO1993019373A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
US7279162B1 (en) 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
US5955074A (en) * 1990-10-22 1999-09-21 Henry M. Jackson Foundation For The Advancement Of Military Medicine Directed human immune globulin for the prevention and treatment of staphylococcal infections
PT783520E (pt) * 1994-09-21 2002-05-31 Henry M Jackson Found Advanc M Anticorpos opsonicos amplamente reactivos que reagem com antigenios de estafilococos comuns
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
AU2006203322B2 (en) * 1997-06-16 2010-04-29 Altor Bioscience Corporation Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
RU2154828C2 (ru) * 1998-07-28 2000-08-20 Красноярская государственная медицинская академия Способ прогноза исхода генерализованной гнойной хирургической инфекции
JP2003503015A (ja) * 1999-05-03 2003-01-28 メダレツクス・インコーポレーテツド スタフィロコッカス・アウレウスに対するヒト抗体
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
PL1745075T3 (pl) 2004-04-21 2013-09-30 Brigham & Womens Hospital Inc Peptydy wiążące poli-N-acetyloglukozaminę (PNAG/DPNAG) i sposoby ich zastosowania
BRPI0516974A (pt) 2004-10-21 2008-09-30 Wyeth Corp composição imunogênica compreendendo um polipeptìdeo; um método para induzir uma resposta imune contra staphylococcus epidermidis; um método para induzir uma resposta imune contra staphylococcus aureus; um método para a detecção e/ou identificação de staphylococcus epidermidis; um método para a detecção e/ou identificação de anticorpos para staphylococcus epidermidis
EP1928999B1 (en) * 2005-08-23 2011-04-13 IQ Corporation Methods of producing stable b-lymphocytes
EP1821053B1 (en) 2006-01-31 2015-11-04 Electrolux Home Products Corporation N.V. Rapid chilling apparatus for beverages and method for controlling the same
CN102159540B (zh) 2008-07-21 2015-08-12 布赖汉姆妇女医院 与合成的β-1,6葡糖胺寡糖相关的方法和组合物
AU2010264538B2 (en) 2009-06-22 2013-10-03 Wyeth Llc Immunogenic compositions of Staphylococcus aureus antigens
US12397014B2 (en) 2019-02-05 2025-08-26 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL81370A (en) * 1986-02-07 1991-06-30 Genetic Systems Corp Pharmaceutical and diagnostic compositions comprising a plurality of human monoclonal antibodies for the treatment of bacterial diseases,methods for the preparation of the compositions and antibodies and kits containing said compositions
WO1988004669A1 (fr) * 1986-12-15 1988-06-30 Mitsui Toatsu Chemicals, Inc. Anticorps monoclonal humain et medicament pour la prophylaxie et le traitement de maladies infectieuses comprenant ledit anticorps en tant qu'ingredient efficace
WO1993017044A1 (en) * 1992-02-25 1993-09-02 U.S. Government, As Represented By The Secretary Of The Army Directed human immune globulin for the prevention and treatment of staphylococcal infections

Also Published As

Publication number Publication date
JPH07507387A (ja) 1995-08-10
EP1033135A1 (en) 2000-09-06
JP4171596B2 (ja) 2008-10-22
DE69329642T3 (de) 2009-05-20
ES2155450T3 (es) 2001-05-16
ES2155450T5 (es) 2008-11-01
JP4353974B2 (ja) 2009-10-28
EP0635132A1 (en) 1995-01-25
GR3035155T3 (en) 2001-04-30
DK0635132T4 (da) 2008-08-25
JP4124816B2 (ja) 2008-07-23
CA2132421C (en) 2010-11-23
DE69329642T2 (de) 2001-03-15
AU3805893A (en) 1993-10-21
CA2132421A1 (en) 1993-09-20
JP2002255998A (ja) 2002-09-11
JP2007119468A (ja) 2007-05-17
IL105119A (en) 1999-06-20
PT635132E (pt) 2001-03-30
DE69329642D1 (de) 2000-12-14
WO1993019373A1 (en) 1993-09-30
ATE197506T1 (de) 2000-11-11
EP0635132B1 (en) 2000-11-08
IL105119A0 (en) 1993-08-18
EP0635132B2 (en) 2008-05-14
EP1027896A1 (en) 2000-08-16

Similar Documents

Publication Publication Date Title
DK0635132T4 (da) Bredt reaktive opsoniske antistoffer, som reagerer med fælles stafylokok-antigener
McCabe et al. Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutant
JP4656728B2 (ja) ブドウ球菌抗原及びワクチン
Spika et al. Serum antibody response to pneumococcal vaccine in children with nephrotic syndrome
ATE302411T1 (de) Diagnose, prophylaxe und behandlung von morbus crohn durch die verwendung des ompc antigens
DK0986577T3 (da) Opsonisk og beskyttende monoklonale og kimære antistoffer specifikke for lipoteichoicsyre af grampositive bakterier
PT827512E (pt) Anticorpo especifico para staphylococcus aureus e sua utilizacao
DK0673418T3 (da) Monoklonale antistoffer rettet mod mikrotubulusassocieret tau-protein, hybridomaer, der secernerer disse antistoffer, antig
ATE425251T1 (de) Impfstoffe welche antiidiotypische antikörper enthalten, die kohlenhydrate von streptococcus gruppe b nachahmen
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
CA2145397A1 (en) Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
DK0476226T3 (da) Monoklonalt antistof mod humant IgE
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
EP0954529A4 (en) Porphyromonas gingivalis antigen for the diagnosis and treatment of periodontitis
DK0783520T3 (da) Bredt reaktive opsoniske antistoffer, som er reaktive mod fælles stafylokok-antigener
Valentin-Weigand et al. Role of α2-macroglobulin in phagocytosis of group A and C streptococci
KR880001815A (ko) 슈도모나스 에루기노사 편모에 대한 단일클론항체
DE3851630D1 (de) Antikörper gegen streptococcus.
DK0513565T3 (da) Monoklonale antistoffer mod plasmin-antiplasmin-komplekset, fremgangsmåde til deres fremstilling og deres anvendelse
Wittner Antigenicity of the M proteins of group A hemolytic streptococci: further evidence for shared determinants among serotypes
EP0450573A3 (en) Antibodies for the treatment and diagnosis of pseudomonas aeruginosa infections
EP0368466A3 (en) Compositions and methods for the treatment and prevention of gram-negative bacterial infections
PT998493E (pt) Epitopos de toxina semelhante a shigella e a sua utilizacao como vacinas e em diagnosticos
ATE103817T1 (de) Gegen pseudomonas aeruginosa-infektionen wirksame praeparationen sowie immunglobulin-g-haeltige, gegen bakterium pseudomonas aeruginosa wirksame praeparationen.
Bruderer et al. The Use of Antibody Specificity and Affinity in Determining the Protectiveness of Human Monoclonal Antibodies Against Fatal Infections with Nosocomial Gram-Negative Bacteria